Cysteine 10 Is a Key Residue in Amyloidogenesis of Human Transthyretin Val30Met

American Journal of Pathology

Volumn 164, Issue 1, 2004, Pages 337-345

  Takaoka, Yutaka ^a,b,d   Ohta, Mika ^b   Miyakawa, Kazuhisa ^c   Nakamura, Osamu ^c   Suzuki, Misao ^b   Takahashi, Kiyoshi ^c   Yamamura, Ken Ichi ^b   Sakaki, Yoshiyuki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^d IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; CYSTEINE 10; PREALBUMIN; UNCLASSIFIED DRUG;

AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENVIRONMENTAL FACTOR; FAMILIAL AMYLOID POLYNEUROPATHY; FIBER; GENE EXPRESSION; HEREDITY; HISTOCHEMISTRY; HYDROGEN BOND; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; RISK FACTOR; TRANSGENE; WILD TYPE; X RAY CRYSTALLOGRAPHY; ANIMAL; CHEMISTRY; DISEASE MODEL; FAMILIAL AMYLOIDOSIS; GENETICS; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; METABOLISM; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE;

AMYLOIDOSIS, FAMILIAL; ANIMALS; CRYSTALLOGRAPHY, X-RAY; CYSTEINE; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; MUTATION; PREALBUMIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSGENES;

EID: 1542574115     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63123-9     Document Type: Article

References (53)

1. Andrade C: A peculiar form of peripheral neuropathy: familial atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 1952, 75:408-427
2. Glenner GG: Amyloid deposits and amyloidosis - the beta-fibrilloses (parts 1 and 2). N Engl J Med 1980, 306:1283-1343
3. Sipe JD, Cohen AS: History of the amyloid fibril. J Struct Biol 2000, 130:88-98
4. Costa PP, Figueira AS, Bravo FR: Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy. Proc Natl Acad Sci USA 1978, 75:4499-4503
5. Westermark P, Pitkanen P, Benson L, Vahlquist A, Olofsson BO, Cornwell III GG: Serum prealbumin and retinol-binding protein in the prealbumin-related senile and familial forms of systemic amyloidosis. Lab Invest 1985, 52:314-318
6. Reilly MM, King RHM: Familial amyloid polyneuropathy. Brain Pathol 1993, 3:165-176
7. Tawara S, Nakazato M, Kangawa K, Matsuo H, Araki S: Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type). Biochem Biophys Res Commun 1983, 116:880-888
8. Saraiva MJ, Costa PP, Goodman DS: Studies on plasma transthyretin (prealbumin) in familial amyloidotic polyneuropathy, Portuguese type. J Lab Clin Med 1983, 102:590-603
9. Sasaki H, Sakaki Y, Matsuo H, Goto I, Kuroiwa Y, Sahashi I, Takahashi A, Shinoda T, Isobe T, Takagi Y: Diagnosis of familial amyloidotic polyneuropathy by recombinant DNA techniques. Biochem Biophys Res Commun 1984, 125:636-642
10. Sasaki H, Sakaki Y, Takagi Y, Sahashi K, Takahashi A, Isobe T, Shinoda T, Matsuo H, Goto I, Kuroiwa Y: Presymptomatic diagnosis of heterozygosity for familial amyloidotic polyneuropathy by recombinant DNA techniques. Lancet 1985, 1:100
11. Mita S, Maeda S, Ide M, Tsuzuki T, Shimada K, Araki S: Familial amyloidotic polyneuropathy diagnosed by cloned human prealbumin cDNA. Neurology 1986, 36:298-301
12. Benson MD, Cohen AS: Generalized amyloid in a family of Swedish origin - a study of 426 family members in seven generations of a new kinship with neuropathy, nephropathy and central nervous system involvement. Ann Intern Med 1977, 86:419-424
13. Sakaki Y, Yoshioka K, Tanahashi H, Furuya H, Sasaki H: Human transthyretin (prealbumin) gene and molecular genetics of familial amyloidotic polyneuropathy. Mol Biol Med 1989, 6:161-168
14. Blake CCF, Swan IDA: An X-ray study of the subunit structure of prealbumin. J Mol Biol 1971, 61:217-224
15. Soprano DR, Herbert J, Soprano KJ, Schon EA, Goodman DS: Demonstration of transthyretin mRNA in the brain and other extrahepatic tissues in the rat. J Biol Chem 1985, 260:11793-11798
16. Terry CJ, Damas AM, Oliveira P, Saraiva MJ, Alves IL, Costa PP, Matias PM, Sakaki Y, Blake CC: Structure of Met30 variant of transthyretin and its amyloidogenic implications. EMBO J 1993, 12:735-741
17. Lai Z, Colon W, Kelly JW: The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry 1996, 35:6470-6482
18. Liu K, Cho HS, Lashuel HA, Kelly JW, Wemmer DE: A glimpse of a possible amyloidogenic intermediate of transthyretin. Nat Struct Biol 2000, 7:754-757
19. Colon W, Kelly JW: Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry 1992, 31:8654-8660
20. Lashuel AH, Lai Z, Kelly JW: Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation. Biochemistry 1998, 37:17851-17864
21. Wakasugi S, Inomoto T, Yi S, Naito M, Uehira M, Iwanaga T, Maeda S, Araki K, Miyazaki J, Takahashi K, Shimada K, Yamamura K-I: A transgenic mouse model of familial amyloidotic polyneuropathy. Proc Jpn Acad 1987, 63:344-347
22. Shimada K, Maeda S, Murakami T, Nishiguchi S, Tashiro F, Yi S, Wakasugi S, Takahashi K, Yamamura K-I: Transgenic mouse model of familial amyloidotic polyneuropathy. Mol Biol Med 1989, 6:333-343
23. Kohno K, Palha JA, Miyakawa K, Saraiva MJ, Ito S, Mabuchi T, Blaner WS, Iijima H, Tsukahara S, Episkopou V, Gottesman ME, Shimada K, Takahashi K, Yamamura K-I, Maeda S: Analysis of amyloid deposition in a transgenic mouse model of homozygous familial amyloidotic polyneuropathy. Am J Pathol 1997, 150:1497-1508
24. Takaoka Y, Tashiro F, Yi S, Maeda S, Takahashi K, Sakaki Y, Yamamura K-I: Comparison of amyloid deposition in two lines of transgenic mouse that model familial amyloidotic polyneuropathy, type I. Transgenic Res 1997, 6:261-269
25. Tsuzuki T, Mita S, Maeda S, Araki S, Shimada K: Structure of the human prealbumin gene. J Biol Chem 1985, 260:12224-12227
26. Toyonaga T, Hino O, Sugai S, Wakasugi S, Abe K, Shichiri M, Yamamura K-I: Chronic active hepatitis in transgenic mice expressing interferon-γ in the liver. Proc Natl Acad Sci USA 1994, 91:614-618
27. Furuya H, Saraiva MJ, Gawinowicz MA, Alves IL, Costa PP, Sasaki H, Goto I, Sakaki Y: Production of recombinant human transthyretin with biological activities toward the understanding of the molecular basis of familial amyloidotic polyneuropathy (FAP). Biochemistry 1991, 30: 2415-2421
28. Takaoka Y, Ideguchi H, Matsuda M, Sakamoto N, Takeuchi T, Fukumaki Y: A novel mutation in the erythrocyte protein 4.2 gene of Japanese patients with hereditary spherocytosis (protein 4.2 Fukuoka). Br J Haematol 1994, 88:527-533
29. Yamamura K-I, Kikutani H, Takahashi N, Taga T, Akira S, Kawai K, Fukuchi K, Kumahara Y, Honio T, Kishimoto T: Introduction of human gamma 1 immunoglobulin genes into fertilized mouse eggs. J Biochem (Tokyo) 1984, 96:357-363
30. Southern EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975, 98:503-517
31. Nagata Y, Tashiro F, Yi S, Murakami T, Maeda S, Takahashi K, Shimada K, Okamura H, Yamamura K-I: A 6-kb upstream region of the human transthyretin gene can direct developmental, tissue-specific, and quantitatively normal expression in transgenic mouse. J Biochem (Tokyo) 1995, 117:169-175
32. Wright JR: Potassium permanganate reaction in amyloidosis. Lab Invest 1977, 36:274-281
33. Isobe S, Chen ST, Nakane PK, Brown WR: Studies on translocation of immunoglobulins across intestinal epithelium. 1. Improvements in the peroxidase-labeled antibody method for application to study of human intestinal mucosa. Acta Histochem Cytochem 1977, 10:161-171
34. Sousa MM, Fernandes R, Palha JA, Taboada A, Vieira P, Saraiva MJ: Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro. Am J Pathol 2002, 161:1935-1948
35. Teng MH, Yin JY, Vidal R, Ghiso J, Kumar A, Rabenou R, Shah A, Jacobson DR, Tagoe C, Gallo G, Buxbaum J: Amyloid and nonfibrillar deposits in mice transgenic for wild-type human transthyretin: a possible model for senile systemic amyloidosis. Lab Invest 2001, 81:385-396
36. Uemichi T, Murrell JR, Zeldenrust S, Benson MD: A new mutant transthyretin (Arg 10) associated with familial amyloid polyneuropathy. J Med Genet 1992, 29:888-891
37. McCutchen SL, Kelly JW: Intermolecular disulfide linkages are not required for transthyretin amyloid fibril formation in vitro. Biochem Biophys Res Commun 1993, 197:415-421
38. Smith CJ, Marnett LJ: Effects of cysteine-to-serine mutations on structural and functional properties of prostaglandin endoperoxide synthase. Arch Biochem Biophys 1996, 335:342-350
39. Noguchi H, Ohta M, Wakasugi S, Noguchi K, Nakamura N, Nakamura O, Miyakawa K, Takeya M, Suzuki M, Nakagata N, Urano T, Ono T, Yamamura K-I: Effect of the intestinal flora on amyloid deposition in a transgenic mouse model of familial amyloidotic polyneuropathy. Exp Anim 2002, 51:309-316
40. Ando Y, Nyhlin N, Suhr O, Holmgren G, Uchida K, Sahly M, Yamashita T, Terasaki H, Nakamura M, Uchino M, Ando M: Oxidative stress is found in amyloid deposits in systemic amyloidosis. Biochem Biophys Res Commun 1997, 232:497-502
41. Sakashita N, Ando Y, Yamashita T, Terazaki H, Ohbayashi M, Ando M, Tajima K, Uchino M, Takahashi K: Familial amyloidotic polyneuropathy type I with extracellular superoxide dismutase mutation: a case report. Hum Pathol 1998, 29:1169-1172
42. Thylen C, Wahlqvist J, Haettner E, Sandgren O, Holmgren G, Lundgren E: Modifications of transthyretin in amyloid fibrils: analysis of amyloid from homozygous and heterozygous individuals with the Met30 mutation. EMBO J 1993, 12:743-748
43. Zhang Q, Kelly JW: Cys10 mixed disulfides make transthyretin more amyloidogenic under mildly acidic conditions. Biochemistry 2003, 42:8756-8761
44. Sasaki H, Yoshioka N, Takagi Y, Sakaki Y: Structure of the chromosomal gene for human serum prealbumin. Gene 1985, 37:191-197
45. Ames BN, Shigenaga MK, Hagen TM: Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993, 90:7915-7922
46. Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, Floyd RA, Markesbery WR: Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci USA 1991, 88:10540-10543
47. Multhaup G, Ruppert T, Schlicksupp A, Hesse L, Bill E, Pipkorn R, Masters CL, Beyreuther K: Copper-binding amyloid precursor protein undergoes a site-specific fragmentation in the reduction of hydrogen peroxide. Biochemistry 1998, 37:7224-7230
48. Ruiz FH, Gonzalez M, Bodini M, Opazo C, Inestrosa NC: Cysteine 144 is a key residue in the copper reduction by the β-amyloid precursor protein. J Neurochem 1999, 73:1288-1292
49. Yi S, Takahashi K, Naito M, Tashiro F, Wakasugi S, Maeda S, Shimada K, Yamamura K, Araki S: Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met30) gene. Pathologic similarity to human familial amyloidotic polyneuropathy, type I. Am J Pathol 1991, 138:403-412
50. Sasaki H, Nakazato M, Saraiva MJ, Matsuo H, Sakaki Y: Activity of a metallothionein-transthyretin fusion gene in transgenic mice. Possible effect of plasmid sequences on tissue-specific expression. Mol Biol Med 1989, 6:345-653
51. Palha JA, Ballinari D, Amboldi N, Cardoso I, Ferrnandes R, Belloti V, Merlini G, Saraiva MJ: 4′-Iodo-4′-deoxydoxorubicin disrupts the fibrillar structure of transthyretin amyloid. Am J Pathol 2000, 156:1919-1925
52. Holmgren G, Steen L, Ekstedt J, Groth CG, Ericzon BG, Eriksson S, Andersen O, Karberg I, Norden G, Nakazato M, Hawkins P, Richardson S, Pepys M: Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-Met30). Clin Genet 1991, 40:242-246
53. Holmgren G, Ericzon BG, Groth CG, Steen L, Suhr O, Andersen O, Wallin BG, Seymour A, Richardson S, Hawkins PN, Pepys MB: Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 1993, 341:1113-1116